Literature DB >> 9545105

Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma.

K Kashima1, S Yokoyama, S Noguchi, N Murakami, H Yamashita, S Watanabe, S Uchino, M Toda, A Sasaki, T Daa, I Nakayama.   

Abstract

A subgroup of patients with papillary thyroid carcinoma (PTC) also has chronic thyroiditis (CT) as an associated disease of the thyroid. To assess the prognostic value of CT in patients with PTC, we reviewed the histological slides of 2225 patients with PTC who had undergone surgery between 1971 and 1992. Of the 2225 patients, 692 were excluded from the analysis because regional lymph nodes and/or nonneoplastic thyroid tissues were unavailable for histological assessment. The series included 281 patients with CT in nonneoplastic thyroid tissue and 1252 without CT. We performed statistical analyzes by the log-rank test and Cox's proportional-hazard method. Sixty-two (5.0%) of the 1252 patients without CT died of metastatic disease during the follow-up period and the relapse-free 10-year survival rate was 85%. By contrast, only 2 (<1.0%) of the 281 patients with CT died, and their relapse-free 10-year survival rate was 95%. The difference between patients with CT and those without CT in terms of relapse-free and overall survival was statistically significant (p < 0.0001). Risk factors for unfavorable outcome were age 45 years or more, absence of psammoma bodies, and absence of CT (p < 0.0001), followed by vascular invasion (p = 0.0007), male sex (p = 0.0013), and metastasis to regional lymph nodes (p = 0.047). Multivariate analysis indicated that all of these factors with the exception of gender were independent factors in the final model for overall survival. Chronic thyroiditis in the nonneoplastic thyroid of patients with PTC is a powerful prognostic factor for both relapse-free and overall survival.

Entities:  

Mesh:

Year:  1998        PMID: 9545105     DOI: 10.1089/thy.1998.8.197

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  46 in total

1.  Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis.

Authors:  Hee Sung Kim; Yoon Jung Choi; Ji-Sup Yun
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

3.  The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Authors:  Young Joo Park; Hwa Young Ahn; Hoon Sung Choi; Kyung Won Kim; Do Joon Park; Bo Youn Cho
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

4.  Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.

Authors:  S Scarpino; A Stoppacciaro; F Ballerini; M Marchesi; M Prat; M C Stella; S Sozzani; P Allavena; A Mantovani; L P Ruco
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.

Authors:  G Mazziotti; M Rotondi; G Manganella; R Franco; V Colantuoni; G Amato; C Carella
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

6.  Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.

Authors:  Y Liu; X Yun; M Gao; Y Yu; X Li
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

7.  The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Authors:  Yun Zhang; Jiaqi Dai; Tingting Wu; Nailin Yang; Zhiqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-12       Impact factor: 4.553

8.  Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.

Authors:  Marina S Carvalho; Pedro W Rosario; Gabriela F Mourão; Maria R Calsolari
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 9.  Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies.

Authors:  Francesco Boi; Fabiana Pani; Stefano Mariotti
Journal:  Eur Thyroid J       Date:  2017-04-24

10.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.